Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 6, 2007, Pages 676.e1-676.e7

  Aletti, Giovanni D ^a   Dowdy, Sean C ^a   Podratz, Karl C ^a   Cliby, William A ^a  

^a MAYO CLINIC   (United States)

Author keywords

ovarian cancer; overall survival; residual disease; short term morbidity; surgical complexity score

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER SURGERY; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS; SURGICAL COMPLEXITY SCORE; SURGICAL TECHNIQUE; THROMBOEMBOLISM;

EID: 36448998169     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.10.495     Document Type: Article

References (14)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER cancer statistics review, 1975-2001. Bethesda (MD): National Cancer Institute. Available at: http://www.seer.cancer.gov/csr/1975_2001/.
3. Fentiman I.S., Tirelli U., Monfardini S., et al. Cancer in the elderly: why so badly treated?. Lancet 335 (1990) 1020-1022
4. Ries L.A.G. Ovarian cancer: survival and treatment differences by age. Cancer 71 (1993) 524-529
5. Fentiman I.S. Denying surgery to elderly people with cancer. Oncol Pract 2 (1998) 12
6. Cloven N.G., Manetta A., Berman M.L., Kohler M.F., and DiSaia P.J. Management of ovarian cancer in patients older than 80 years of age. Gynecol Oncol 73 (1999) 137-139
7. Díaz-Montes T.P., Zahurak M.L., Giuntoli II R.L., et al. Surgical care of elderly women with ovarian cancer: a population-based perspective. Gynecol Oncol 99 (2005) 352-357
8. Cliby W.A., Aletti G.D., Wilson T.O., and Podratz K.C. Is it justified to classify patients to stage IIIC epithelial ovarian cancer based on nodal involvement only?. Gynecol Oncol 103 (2006) 797-801
9. Announcements: FIGO stages-1988 revision. Gynecol Oncol 35 (1989) 125-126
10. Aletti G.D., Dowdy S.C., Podratz K.C., and Cliby W.A. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol 195 (2006) 1862-1868
11. Alberts D.S., Dahlberg S., Green S.J., et al. Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. Cancer 71 (1993) 618-627
12. Freyer G., Geay J.F., Touzet S., et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 16 (2005) 1795-1800
13. Aletti G.D., Gostout B.S., Podratz K.C., and Cliby W.A. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol 100 (2006) 33-37
14. Wenzel L., Huang H.Q., Monk B.J., Rose P.G., and Cella D. Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 23 (2005) 5605-5612